Dockets
Federal rulemakings, soonest-closing first — each gathers its documents and comments.
Agency ▾
Requests that FDA, under FDCA §505G(b) (OTC monograph administrative order process), amend OTC Monograph M013 to update Drug Facts labeling for all over-the-counter acetaminophen-containing products. In the alternative, Petitioner asks FDA to initiate such an order on its own
Rear Designated Seating Position Alert
Knockout Mosquito Systems LLC - Exemption/Rulemaking
Request for Comments on the Science and Technology Report; Establishment of Docket; Request for Comments
Endangered and Threatened Wildlife and Plants; 90-Day Finding for Three Petitions To List the Yellowstone Bison
Cannabis and Cannabis-Derived Compounds: Quality Considerations for Clinical Research; Draft Guidance for Industry; Availability
Requests that the FDA Admit "Waste Parity" Status: Formally acknowledge that the active estrogenic metabolites used in approved conjugated equine estrogen (CEE) pharmaceuticals (such as Premarin) are molecularly identical to the raw equine metabolites the Agency classifies as prohibited "filth" under Section 402(a)(3) of the FD&C Act
Requests that the FDA evaluate and assume jurisdiction over GonaCon-Equine and ZonaStat-H as New Animal Drugs.
Request that the FDA publicly release documentation sufficient to establish that the aluminum content in Adacel, Boostrix, Engerix-B, Havrix, Infanrix, Infanrix hexa, Kinrix, Pediarix, Pedvax-HIB, Pentacel, Prevnar-13, Synflorix, and Vaqtais is consistent with amount provided in its labeling and pause distribution of each Subject Vaccine
Delta Air Lines, Inc. - Exemption/Rulemaking
The Declaration of Allulose and Calories from Allulose on Nutrition and Supplement Facts Labels: Draft Guidance for Industry; Availability
97-8-14 Order Authorizing Subsidy for Increased Program-Wide - re: EAS at Massena, New York